SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-20-026041
Filing Date
2020-10-01
Accepted
2020-10-01 17:07:01
Documents
2
Period of Report
2020-09-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 4036
2 POWER OF ATTORNEY (PUBLIC): UPDATEDPOA doc1.txt EX-24 3040
  Complete submission text file 0001127602-20-026041.txt   8424
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Issuer) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404
Business Address
Lofton Kevin E (Reporting) CIK: 0001468818 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19731 | Film No.: 201216985